87 related articles for article (PubMed ID: 2822140)
21. 1,25-Dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells.
Yamaoka K; Marion SL; Gallegos A; Haussler MR
Biochem Biophys Res Commun; 1986 Sep; 139(3):1292-8. PubMed ID: 3021153
[TBL] [Abstract][Full Text] [Related]
22. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
23. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
Biochem Pharmacol; 1990 Oct; 40(8):1827-32. PubMed ID: 2173591
[TBL] [Abstract][Full Text] [Related]
24. Hormonal regulation of vitamin D receptor levels and osteocalcin synthesis in human osteosarcoma cells.
Mäenpää P; Mahonen A; Pirskanen A
Calcif Tissue Int; 1991; 49 Suppl():S85-6. PubMed ID: 1657330
[TBL] [Abstract][Full Text] [Related]
25. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
Norman AW; Sergeev IN; Bishop JE; Okamura WH
Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
[TBL] [Abstract][Full Text] [Related]
26. Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in a clonal osteoblast-like rat osteogenic sarcoma cell line.
Matsumoto T; Kawanobe Y; Morita K; Ogata E
J Biol Chem; 1985 Nov; 260(25):13704-9. PubMed ID: 2997179
[TBL] [Abstract][Full Text] [Related]
27. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
[TBL] [Abstract][Full Text] [Related]
28. Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells.
Chen TL; Hauschka PV; Feldman D
Endocrinology; 1986 Mar; 118(3):1119-26. PubMed ID: 3004896
[TBL] [Abstract][Full Text] [Related]
29. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
[TBL] [Abstract][Full Text] [Related]
30. Responsiveness of the intestinal 1,25-dihydroxyvitamin D3 receptor to magnesium depletion in the rat.
Lemay J; Gascon-Barré M
Endocrinology; 1992 May; 130(5):2767-77. PubMed ID: 1315257
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
[TBL] [Abstract][Full Text] [Related]
32. Homologous and heterologous regulation of 1,25-dihydroxyvitamin D-3 receptor mRNA levels in human osteosarcoma cells.
Mahonen A; Pirskanen A; Mäenpää PH
Biochim Biophys Acta; 1991 Jan; 1088(1):111-8. PubMed ID: 1846564
[TBL] [Abstract][Full Text] [Related]
33. 1 alpha, 25-Dihydroxyvitamin D3 specifically induces its own metabolism in a human cancer cell line.
Eisman JA; Sher E; Suva LJ; Frampton RJ; McLean FL
Endocrinology; 1984 Apr; 114(4):1225-31. PubMed ID: 6323135
[TBL] [Abstract][Full Text] [Related]
34. Physiological effects of 1,25-dihydroxyvitamin D3 in TM4 Sertoli cell line.
Akerstrom VL; Walters MR
Am J Physiol; 1992 Jun; 262(6 Pt 1):E884-90. PubMed ID: 1319682
[TBL] [Abstract][Full Text] [Related]
35. 1 alpha,25-dihydroxyvitamin D3 receptors in cultured rat osteoblast-like cells. Glucocorticoid treatment increases receptor content.
Chen TL; Cone CM; Morey-Holton E; Feldman D
J Biol Chem; 1983 Apr; 258(7):4350-5. PubMed ID: 6300083
[TBL] [Abstract][Full Text] [Related]
36. 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor.
Colston K; Wilkinson JR; Coombes RC
Endocrinology; 1986 Jul; 119(1):397-403. PubMed ID: 3013595
[TBL] [Abstract][Full Text] [Related]
37. 1,25-Dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells.
Mulkins MA; Manolagas SC; Deftos LJ; Sussman HH
J Biol Chem; 1983 May; 258(10):6219-25. PubMed ID: 6189822
[TBL] [Abstract][Full Text] [Related]
38. 1,25-dihydroxyvitamin D3 receptors in the seminiferous tubules of the rat testis increase at puberty.
Walters MR
Endocrinology; 1984 Jun; 114(6):2167-74. PubMed ID: 6327237
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3.
Arbour NC; Prahl JM; DeLuca HF
Mol Endocrinol; 1993 Oct; 7(10):1307-12. PubMed ID: 8264662
[TBL] [Abstract][Full Text] [Related]
40. Constitutive expression of a vitamin D 1-hydroxylase in a myelomonocytic cell line: a model for studying 1,25-dihydroxyvitamin D production in vitro.
Adams JS; Beeker TG; Hongo T; Clemens TL
J Bone Miner Res; 1990 Dec; 5(12):1265-9. PubMed ID: 1963733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
